Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2006
11/28/2006CA2026915C Stem cell factor
11/28/2006CA1341516C Preparation of factor x111a by gene manipulation
11/23/2006WO2006125068A2 Production of enzymes
11/23/2006WO2006124269A2 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
11/23/2006WO2006123926A2 Peptide composition for growing and/or culturing micro-organisms and/or cells
11/23/2006WO2006123829A1 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
11/23/2006WO2006123445A1 Method of displaying protein
11/23/2006WO2006093998A3 Process and genes for expression and over-expression of active [fefe] hydrogenases
11/23/2006WO2006055778A3 Immunoglobulin variable region cassette exchange
11/23/2006WO2005116267A3 Emission ratiometric indicators of phosphorylation by c-kinase
11/23/2006WO2005038002A3 Site-specific incorporation of redox active amino acids into proteins
11/23/2006WO2004022720A3 Methods for identifying antimicrobial compounds
11/23/2006US20060265787 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
11/23/2006US20060265769 Gab2 (p97) gene and methods of use thereof
11/23/2006US20060265767 Compositions and methods for treatment of autoimmune and related diseases
11/23/2006US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006US20060264615 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12; site directed mutagenesis
11/23/2006US20060264613 Soluble CTLA4 proteins produced by recombinant DNA methods; autoimmune diseases, transplant rejection; inhibits the co-stimulatory pathway in T cell activation
11/23/2006US20060264612 Optimised protein synthesis
11/23/2006US20060264611 Pancreatic islet transcription factor and uses thereof
11/23/2006US20060264610 Protein complexes of the tip60 transcriptional activator protein
11/23/2006US20060264609 Use of heat shock proteins
11/23/2006US20060264606 Processes for making acylated insulin
11/23/2006US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
11/23/2006US20060264392 Modulators of angiogenesis
11/23/2006US20060264373 Modified vitamin K-dependent polypeptides
11/23/2006US20060264370 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith
11/23/2006US20060263882 Multi-cistronic vectors for gene transfer protocols
11/23/2006US20060263877 Novel megakaryocytic protein tyrosine kinase 1
11/23/2006US20060263867 Delta-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
11/23/2006US20060263866 Delta-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
11/23/2006US20060263861 Method for producing beta-hydroxy amino acid and enzyme used therefor
11/23/2006US20060263858 Hyaluronan synthase genes and expression thereof in Bacillus hosts
11/23/2006US20060263857 Compositions and methods for immunomodulation in an organism
11/23/2006US20060263856 Expression technology for proteins containing a hybrid isotype antibody moiety
11/23/2006US20060263855 Intein-mediated protein purification using in vivo expression of an elastin-like protein
11/23/2006US20060263854 Immunodiagnostic assays using reducing agents
11/23/2006US20060263853 Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
11/23/2006US20060263852 Asp2
11/23/2006US20060263851 Soluble interleukin-20 receptor
11/23/2006US20060263850 to inhibit cytokine-mediated inflammation; two polypeptide subunits, IL-20RA (formerly ZcytoR7) and IL-20RB (formerly DIRS1); one subunit fused to constant region of light chain of an immunoglobulin; the other fused to constant region of heavy chain; light and heavy chains connected via a disulfide bond
11/23/2006US20060263849 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo
11/23/2006US20060263848 Cysteine-containing peptides having antioxidant properties
11/23/2006US20060263847 Compositions and methods for treatment of sever acute respiratory syndrome (sars)
11/23/2006US20060263846 S. penumoniae antigens
11/23/2006US20060263838 Soluble pyrroloquinoline quinone; culturing microorganisms; thermal stability
11/23/2006US20060263828 Arrestin chimera comprising naturally occurring beta-arrestin-2 and naturally occurring ubiquitin moiety, where arrestin chimera has increased affinity for GPCR, and where increased affinity means that arrestin chimera remains associated with and traffics with GPCR into endosomes
11/23/2006US20060263820 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins
11/23/2006US20060263804 Functional influenza virus-like particles (VLPs)
11/23/2006US20060263788 Human kinase interacting protein 2 (KIP2)-related gene variant (KIP2V1) associated with prostate cancer
11/23/2006US20060263787 Immunoglobulin-like variable chain binding polypeptides and methods of use
11/23/2006US20060263786 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
11/23/2006US20060263776 Serine protease
11/23/2006US20060263775 cDNA molecule of a mammalian ELF3 gene; associated with cancer, including ELF3 mRNA intron retention, a novel ELF3 5' untranslated region, and a novel Alu, Alukwd
11/23/2006US20060263774 Nucleotide sequences, vectors, transformed host cells, polypeptides, antibodies; monocyte/macrophage mediated disorders
11/23/2006US20060263770 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
11/23/2006US20060263377 Surface protein of Leptospira
11/23/2006US20060263366 Neoplasm specific antibodies and uses thereof
11/23/2006US20060263361 Pan-kir2dl nk -receptor antibodies and their use in diagnostik and therapy
11/23/2006US20060263356 antibody binding to IL-13R alpha 1, inhibiting IL-13 bioactivity; comprising variable heavy and light chain amino acid sequences CDR1, CDR2, and CDR3; useful in the treatment of asthma and allergic diseases
11/23/2006US20060263353 untagged antigen is used in conjunction with a polyclonal antibody to isolate cells recognizing the antigen; for cancers, autoimmune or inflammatory disorders
11/23/2006US20060263345 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
11/23/2006US20060263334 Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen
11/23/2006DE102006019794A1 Use of glycerylglycosides for stimulating aquaporin expression and in the preparation of cosmetics
11/23/2006CA2607291A1 Compositions and methods for modulating immune responses
11/23/2006CA2606576A1 High-level expression of recombinant antibody in a mammalian host cell
11/23/2006CA2597511A1 Hivcon: an hiv immunogen and uses thereof
11/22/2006EP1724354A2 Circular DNA molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy
11/22/2006EP1724349A1 TIE Ligand Homologues
11/22/2006EP1724342A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli
11/22/2006EP1724284A2 GLP-1 fusion proteins
11/22/2006EP1722808A2 Egf receptor epitode peptides and uses thereof
11/22/2006EP1722760A2 Delivery of genes encoding short hairpin rna using receptor-specific nanocontainers
11/22/2006EP1626981A4 Dipeptidyl-peptidase protected proteins
11/22/2006EP1558746A4 Nucleic acids encoding duramycin
11/22/2006EP1556694A4 Method of isolation and self-assembly of small protein particles from blood and other biological materials
11/22/2006EP1373571B1 Functional surface display of polypeptides
11/22/2006EP1370575B1 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/22/2006EP1266025B1 Protein scaffolds for antibody mimics and other binding proteins
11/22/2006EP1163522B1 Method for detecting msrv-1 induced superantigen activity in a biological sample
11/22/2006EP1078054B1 Monomeric mp52/gdf-5 with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
11/22/2006EP1037603B1 Membrane virus host range mutations and their uses as vaccine substrates
11/22/2006EP1015570B1 Fibrin microbeads and uses thereof
11/22/2006EP0999273B1 HUMAN GENE RecQ4 ENCODING HELICASE
11/22/2006EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006EP0935415B1 In vitro methods for delivering nucleic acids into a cell
11/22/2006EP0890105B1 Methods related to Alzheimer's disease for diagnosis, manufacture of medicaments and screening of substances and beta-amyloid related peptides
11/22/2006EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/22/2006EP0783003B1 G-CSF TPO fusion proteins
11/22/2006EP0574461B2 High affinity humanized monoclonal antibodies
11/22/2006CN1867669A Method for producing gamma-carboxylated proteins
11/22/2006CN1867581A Il-21衍生物 Il-21 derivatives
11/22/2006CN1865445A scFvC6.5-sTrail fusion gene and protein, and its preparation
11/22/2006CN1285732C Method for preparing polyclonal antibody of human vascular endothelial growth factor
11/22/2006CN1285731C Method for enzyme hydrolyzing zein through two steps method
11/22/2006CN1285608C Parainfluenza virus glycoproteins and vaccines
11/22/2006CN1285381C Chemokine mutants in treatment of multiple sclerosis
11/21/2006US7139665 Generating mutant aminoacyl transfer RNA synthetase for de novo design of artificial proteins
11/21/2006US7138568 Expression vector coding insecticidal protein for use in the transformation and generation of moth resistant leafy plants
11/21/2006US7138515 Translational activity-promoting higher-order structure